
Researchers have turned to London to trial therapeutic benefits of psychedelic medicines (Stock image)
(Picture: PA Archive)North American drug developers have signed a deal with a British company to trial the therapeutic benefits of psychedelic medicines in London.
Canada and US-based drug developers Mindset, PharmAla, Mydecine and Psyence have partnered with Clerkenwell Health, a clinical research firm, to trial their drugs in the capital.